Flanders, NJ, United States of America

Alan Meyers

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Revlon Consumer Products Corporation. Active years: 2016.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alan Meyers: Innovator in Cosmetic Chemistry

Introduction

Alan Meyers is a notable inventor based in Flanders, NJ (US). He has made significant contributions to the field of cosmetic chemistry, particularly in the development of compounds that promote skin health. His innovative work has led to the creation of a patent that addresses important aspects of cosmetic formulations.

Latest Patents

Alan Meyers holds a patent for "Glycyrrhetinimidyl hydroxyproline alkyl esters and protected derivatives thereof." This invention focuses on glycyrrhetinimidyl hydroxyproline alkyl ester compounds and their protected derivatives, as well as cosmetically acceptable salts. The patent outlines methods for making these compounds, cosmetic compositions that include them, and their application in promoting collagen production in human skin. The compounds and compositions derived from this invention offer various beneficial properties for skin health.

Career Highlights

Alan Meyers is associated with Revlon Consumer Products Corporation, where he applies his expertise in cosmetic formulations. His work at Revlon has allowed him to contribute to the development of innovative products that enhance skin care.

Collaborations

Some of his coworkers include Harry Cai and Dariush Hosseinpour, who collaborate with him on various projects within the company.

Conclusion

Alan Meyers is a distinguished inventor whose work in cosmetic chemistry has led to advancements in skin care products. His patent for glycyrrhetinimidyl hydroxyproline alkyl esters exemplifies his commitment to improving human skin health through innovative formulations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…